The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Cognitive enhancement as a treatment for drug addictions
Open accessAbstract
Drug addiction continues to be an important public health problem, with an estimated 22.6 million current illicit drug users in the United States alone. For many addictions, including cocaine, methamphetamine, and marijuana addiction, there are no approved pharmacological treatments. Behavioral treatments are effective but effects vary widely across individuals. Treatments that are effective across multiple addictions are greatly needed, and accumulating evidence suggests that one such approach may be pharmacological or behavioral interventions that enhance executive inhibitory control in addicts. Current evidence indicates that most forms of chronic drug use may be associated with significant cognitive impairments, especially in attention, working memory, and response inhibition functions. In some studies, these impairments predict poor treatment retention and outcome. A number of cognitive enhancing agents, including galantamine, modafinil, atomoxetine, methylphenidate, and guanfacine, have shown promising findings in human studies. Specific behavioral interventions, including cognitive remediation, also show promise. However, whether improvement of selective cognitive functions reduces drug use behavior remains to be determined. Cognitive enhancement to improve treatment outcomes is a novel strategy worthy of future research, as are related questions such as whether these approaches may be broadly beneficial to most addicts or best reserved for substance users with specific demonstrated cognitive impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749
Hettema, J., Steele, J., & Miller, W. R. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143833 · Cited by 1,803
The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials
Burke, B. L., Arkowitz, H., & Menchola, M. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.5.843 · Cited by 1,575 · cited 1×
“For example, CBT, CM, and MI have been found to be effective across alcohol, cannabis, and cocaine use disorders (Burke et al., 2003; Dutra et al., 2008; Lussier et al., 2006; Marijuana Treatment Project Research Group, 2004; Miller and Wilbourne, 2002).”
BackgroundIndividual differences in executive functions are almost entirely genetic in origin.
Friedman, N. P., Miyake, A., Young, S. E., DeFries, J. C., Corley, R. P., & Hewitt, J. K. (2008) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.137.2.201 · Cited by 1,547
Impulsivity as a determinant and consequence of drug use: a review of underlying processes
de Wit, H. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00129.x · Cited by 1,415
Attentional bias in addictive behaviors: A review of its development, causes, and consequences
FIELD, M., & COX, W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.030 · Cited by 1,376
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Alcohol dependence: Provisional description of a clinical syndrome
Edwards, G., & Gross, M. M. (1976) · BMJ · doi:10.1136/bmj.1.6017.1058 · Cited by 1,163
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Training, maturation, and genetic influences on the development of executive attention
Rueda, M. R., Rothbart, M. K., McCandliss, B. D., Saccomanno, L., & Posner, M. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506897102 · Cited by 1,110
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
Insights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
Attention, self–regulation and consciousness
The American Association for Research into Nervous and Mental Diseases, Posner, M. I., & Rothbart, M. K. (1998) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1998.0344 · Cited by 917
Wiers, R. W., Eberl, C., Rinck, M., Becker, E. S., & Lindenmeyer, J. (2011) · Psychological Science · doi:10.1177/0956797611400615 · Cited by 912
Hakamata, Y., Lissek, S., Bar-Haim, Y., Britton, J. C., Fox, N. A., Leibenluft, E., Ernst, M., & Pine, D. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.021 · Cited by 869
A meta-analysis of voucher-based reinforcement therapy for substance use disorders
Lussier, J. P., Heil, S. H., Mongeon, J. A., Badger, G. J., & Higgins, S. T. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01311.x · Cited by 858
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders
Miller, W. R., & Wilbourne, P. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00019.x · Cited by 805
Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment
Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798
Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches
Franken, I. H. A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00081-2 · Cited by 763
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Substance Abuse and Mental Health Services Administration
(2009) · Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery · doi:10.4135/9781412964500.n301 · Cited by 720
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
Remember the Future: Working Memory Training Decreases Delay Discounting Among Stimulant Addicts
Bickel, W. K., Yi, R., Landes, R. D., Hill, P. F., & Baxter, C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.017 · Cited by 704
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
Hester, R., & Garavan, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3321-04.2004 · Cited by 657
Adrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 18×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript neuromodulators have powerful influences over PFC functions (Robbins and Arnsten, 2009).”
BackgroundInfluentialMotivation for treatment: A review with special emphasis on alcoholism.
Miller, W. R. (1985) · Psychological Bulletin · doi:10.1037//0033-2909.98.1.84 · Cited by 620
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Field, M., Munafò, M. R., & Franken, I. H. A. (2009) · Psychological Bulletin · doi:10.1037/a0015843 · Cited by 602
Widespread and sustained cognitive deficits in alcoholism: a meta-analysis.
Stavro, K., Pelletier, J., & Potvin, S. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00418.x · Cited by 594
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Retraining automatic action-tendencies to approach alcohol in hazardous drinkers.
Wiers, R. W., Rinck, M., Kordts, R., Houben, K., & Strack, F. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02775.x · Cited by 582
Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573
Methylphenidate: Its Pharmacology and Uses
CHALLMAN, T. D., & LIPSKY, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 553
A behavioral approach to achieving initial cocaine abstinence
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1218 · Cited by 550
Eagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00334-4 · Cited by 543
Impaired inhibitory control of behavior in chronic cocaine users
Fillmore, M. T., & Rush, C. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00206-x · Cited by 519
Major depression and comorbid substance use disorders
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f32408 · Cited by 498
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493 · cited 1×
“4.1.2 Working Memory—Working memory refers to the ability to keep in mind an event that had just been experienced or retrieve information from long-term memory storage and use this information to regulate behavior (Arnsten, 2011).”
BackgroundInfluentialRelapse prevention: introduction and overview of the model
Marlatt, G. A., & George, W. H. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb03867.x · Cited by 476
Relapse Prevention: Introduction and Overview of the Model
Marlatt, G. A., & George, W. H. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb00274.x · Cited by 475
Handbook of Implicit Cognition and Addiction
Wiers, R., & Stacy, A. (2006) · doi:10.4135/9781412976237 · Cited by 474
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Self-citationDeficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Janes, A. C., Pizzagalli, D. A., Richardt, S., Frederick, B. D., Chuzi, S., Pachas, G., Culhane, M. A., Holmes, A. J., Fava, M., Evins, A. E., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.034 · Cited by 416
Carboni, E., Tanda, G. L., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 411
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
GRANT, I., GONZALEZ, R., CAREY, C. L., NATARAJAN, L., & WOLFSON, T. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703950016 · Cited by 411
Carroll, K. M., Ball, S. A., Martino, S., Nich, C., Babuscio, T. A., Nuro, K. F., Gordon, M. A., Portnoy, G. A., & Rounsaville, B. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111835 · Cited by 405 · cited 2×
“Computer-based CBT also allows users to pace the presentation of information, repeat material as often as required, be presented with multiple examples of effective skill implementation through videotaped demonstrations, and thus have multiple opportunities for clarification, evaluation and consolidation of learning (…”
BackgroundSelf-citationCognitive deficits predict low treatment retention in cocaine dependent patients
Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.08.003 · Cited by 397
Mitchell, R. L. C., & Phillips, L. H. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.06.030 · Cited by 397
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384
Emerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
Clinical effectiveness of attentional bias modification training in abstinent alcoholic patients
Schoenmakers, T. M., de Bruin, M., Lux, I. F. M., Goertz, A. G., Van Kerkhof, D. H. A. T., & Wiers, R. W. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.022 · Cited by 373
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
The Residual Cognitive Effects of Heavy Marijuana Use in College Students
Pope, H. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530310027028 · Cited by 350
McNally, R. J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.01.003 · Cited by 348
Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030013002 · Cited by 348
Self-citationZakzanis, K. K. (2001) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/16.7.653 · Cited by 346
Li, C.-S. R., & Sinha, R. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.003 · Cited by 345
Alcohol attentional bias as a predictor of alcohol abusers’ treatment outcome
Cox, W. M., Hogan, L. M., Kristian, M. R., & Race, J. H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00219-3 · Cited by 340
Attentional bias predicts outcome in smoking cessation.
Waters, A. J., Shiffman, S., Sayette, M. A., Paty, J. A., Gwaltney, C. J., & Balabanis, M. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.4.378 · Cited by 332
Self-citationBrief treatments for cannabis dependence: Findings from a randomized multisite trial
Babor, T. F., & The Marijuana Treatment Project Research Group (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.3.455 · Cited by 313
Neurocognitive Deficits in Cocaine Users: A Quantitative Review of the Evidence
Jovanovski, D., Erb, S., & Zakzanis, K. K. (2005) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490515694 · Cited by 313
Aharonovich, E. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00092-9 · Cited by 300
MEDINA, K. L., HANSON, K. L., SCHWEINSBURG, A. D., COHEN-ZION, M., NAGEL, B. J., & TAPERT, S. F. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707071032 · Cited by 296
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288
Implicit cognition and substance use: a meta-analysis
Rooke, S. E., Hine, D. W., & Thorsteinsson, E. B. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.06.009 · Cited by 278
Prefrontal Cortical Dysfunction in Abstinent Cocaine Abusers
Bolla, K. (2004) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16.4.456 · Cited by 257
Neurocognitive consequences of marihuana—a comparison with pre-drug performance
Fried, P. A., Watkinson, B., & Gray, R. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.11.003 · Cited by 253
Chronic Cigarette Smoking: Implications for Neurocognition and Brain Neurobiology
Durazzo, T. C., Meyerhoff, D. J., & Nixon, S. J. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7103760 · Cited by 251
Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation
Gruber, S. A., & Yurgelun-Todd, D. A. (2005) · Cognitive Brain Research · doi:10.1016/j.cogbrainres.2005.02.016 · Cited by 242
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review
Hart, C. L., Marvin, C. B., Silver, R., & Smith, E. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.276 · Cited by 240
Abnormal brain activity in prefrontal brain regions in abstinent marijuana users
Eldreth, D. A., Matochik, J. A., Cadet, J. L., & Bolla, K. I. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.032 · Cited by 239
Handbook of Implicit Cognition and Addiction
BÜHRINGER, G. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01865.x · Cited by 235
Cognitive Performance of Current Methamphetamine and Cocaine Abusers
Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_06 · Cited by 228
Brewer, J. A., Worhunsky, P. D., Carroll, K. M., Rounsaville, B. J., & Potenza, M. N. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.024 · Cited by 226
Self-citationTargeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
Wallace, T. L., & Porter, R. H. P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.034 · Cited by 224
Varenicline improves mood and cognition during smoking abstinence
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222 · cited 1×
“In a recent study of cigarette smokers, 10 days of varenicline treatment improved working memory and attention impairments induced by nicotine withdrawal (Patterson et al., 2009).”
BackgroundLevin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220 · cited 1×
“Methylphenidate also showed promise in reducing cocaine use in individuals with co-morbid ADHD and cocaine addiction (Levin et al., 2007).”
BackgroundDifferential impairments of selective attention due to frequency and duration of cannabis use
Solowij, N., Michie, P. T., & Fox, A. M. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00178-6 · Cited by 217
Neuroscience of Behavioral and Pharmacological Treatments for Addictions
Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.009 · Cited by 214
Self-citationSwanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson, K. A., & Bymaster, F. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.022 · Cited by 214
Heil, S. H., Holmes, H. W., Bickel, W. K., Higgins, S. T., Badger, G. J., Laws, H. F., & Faries, D. E. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00053-4 · Cited by 198
Alcohol and the prefrontal cortex
Abernathy, K., Chandler, L. J., & Woodward, J. J. (2010) · International Review of Neurobiology · doi:10.1016/s0074-7742(10)91009-x · Cited by 196
The residual neuropsychological effects of cannabis: the current status of research
Pope, H. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01097-i · Cited by 196
Performance on the Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals
Streeter, C. C., Terhune, D. B., Whitfield, T. H., Gruber, S., Sarid-Segal, O., Silveri, M. M., Tzilos, G., Afshar, M., Rouse, E. D., Tian, H., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301465 · Cited by 192
Working memory deficits predict short-term smoking resumption following brief abstinence
Patterson, F., Jepson, C., Loughead, J., Perkins, K., Strasser, A. A., Siegel, S., Frey, J., Gur, R., & Lerman, C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.020 · Cited by 190
Guanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans
Jäkälä, P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00127-4 · Cited by 189
Carpenter, K. M., Schreiber, E., Church, S., & McDowell, D. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.04.012 · Cited by 189
Prefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188
Long-term effects of frequent cannabis use on working memory and attention: an fMRI study
Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., & Ramsey, N. F. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0298-7 · Cited by 186
The effects of cocaine: A shifting target over the course of addiction
Porrino, L. J., Smith, H. R., Nader, M. A., & Beveridge, T. J. R. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.040 · Cited by 179
Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors
Powell, J., Dawkins, L., West, R., Powell, J., & Pickering, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1975-8 · Cited by 174
Wexler, B. E., Anderson, M., Fulbright, R. K., & Gore, J. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1694 · Cited by 172
Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence
Li, C.-S. R., Milivojevic, V., Kemp, K., Hong, K., & Sinha, R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.008 · Cited by 167
Nestor, L. J., Ghahremani, D. G., Monterosso, J. R., & London, E. D. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.010 · Cited by 161
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
Sofuoglu, M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02791.x · Cited by 161
Self-citationA double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159
Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.015 · Cited by 159
Neuropsychological profiling of impulsivity and compulsivity in cocaine dependent individuals
Fernández-Serrano, M. J., Perales, J. C., Moreno-López, L., Pérez-García, M., & Verdejo‐García, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2485-z · Cited by 151
Nandam, L. S., Hester, R., Wagner, J., Cummins, T. D. R., Garner, K., Dean, A. J., Kim, B.-N., Nathan, P. J., Mattingley, J. B., & Bellgrove, M. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.014 · Cited by 149
The Orbital Prefrontal Cortex and Drug Addiction in Laboratory Animals and Humans
Everitt, B. J., Hutcheson, D. M., Ersche, K. D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1401.022 · Cited by 144
Augmented Prefrontal Acetylcholine Release during Challenged Attentional Performance
Kozak, R., Bruno, J. P., & Sarter, M. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi079 · Cited by 144
Do cognitive impairments recover following cessation of cannabis use ?
Solowij, N. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00197-e · Cited by 133
Bell, M. D., BRYSON, G. J., Greig, T. C., Fiszdon, J. M., & Wexler, B. E. (2005) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2005.03.0061 · Cited by 132
Smoking and Cognitive Decline Among Middle-Aged Men and Women: The Doetinchem Cohort Study
Nooyens, A. C. J., van Gelder, B. M., & Verschuren, W. M. M. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.130294 · Cited by 131
Smoking History and Cognitive Function in Middle Age From the Whitehall II Study
Sabia, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1165 · Cited by 128
Schilström, B., Ivanov, V., Wiker, C., & Svensson, T. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301087 · Cited by 128
Kiluk, B. D., Nich, C., Babuscio, T., & Carroll, K. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03076.x · Cited by 128
Self-citationThe residual cognitive effects of heavy marijuana use in college students
Jnr, H. G. P., & Yurgelun-Todd, D. A. (1996) · Journal of Clinical Forensic Medicine · doi:10.1016/s1353-1131(96)90030-9 · Cited by 127
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1993-5 · Cited by 127
Loughead, J., Ray, R., Wileyto, E. P., Ruparel, K., Sanborn, P. M., Siegel, S. J., Gur, R. C., & Lerman, C. E. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.016 · Cited by 124
Ghahremani, D. G., Tabibnia, G., Monterosso, J. R., Hellemann, G., Poldrack, R. A., & London, E. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.233 · Cited by 123
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
Goldstein, R. Z., Woicik, P. A., Maloney, T., Tomasi, D. G., Alia‐Klein, N., Shan, J., Honorio, J., Samaras, D., Wang, R., Telang, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011455107 · Cited by 121
Detected, selected, and sometimes neglected: cognitive processing of cues in addiction.
Ryan, F. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.2.67 · Cited by 120
Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117
A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers
Durazzo, T. C., Meyerhoff, D. J., & Nixon, S. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.019 · Cited by 113
Guanfacine treatment of cognitive impairment in schizophrenia
Friedman, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00249-4 · Cited by 113
DeVito, E. E., Blackwell, A. D., Clark, L., Kent, L., Dezsery, A. M., Turner, D. C., Aitken, M. R. F., & Sahakian, B. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1337-y · Cited by 112
Self-citationHeinzerling, K. G., Swanson, A.-N., Kim, S., Cederblom, L., Moe, A., Ling, W., & Shoptaw, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.023 · Cited by 105 · cited 1×
“Modafinil has also shown promise in randomized clinical trials for the treatment of methamphetamine addiction (Heinzerling et al., 2010; Shearer et al., 2009).”
BackgroundA Pilot Double‐Blind Treatment Trial of Memantine for Alcohol Dependence
Evans, S. M., LEVIN, F. R., Brooks, D. J., & Garawi, F. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00360.x · Cited by 105
Out for a Smoke: The Impact of Cigarette Craving on Zoning Out During Reading
Sayette, M. A., Schooler, J. W., & Reichle, E. D. (2009) · Psychological Science · doi:10.1177/0956797609354059 · Cited by 105
Cognitive-motivational predictors of excessive drinkers’ success in changing
Cox, W. M., Pothos, E. M., & Hosier, S. G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0736-9 · Cited by 103
Emerging pharmacological strategies in the fight against cocaine addiction
Sofuoglu, M., & Kosten, T. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.1.91 · Cited by 101
Self-citationLi, C. R., MORGAN, P. T., Matuskey, D., Abdelghany, O., Luo, X., Chang, J. L. K., Rounsaville, B. J., Ding, Y., & Malison, R. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002467107 · Cited by 99
A role for dopamine in the processing of drug cues in heroin dependent patients
Franken, I. H. A., Hendriks, V. M., Stam, C. J., & van den Brink, W. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.02.004 · Cited by 97
Onur, O. A., Schlaepfer, T. E., Kukolja, J., Bauer, A., Jeung, H., Patin, A., Otte, D.-M., Shah, N. J., Maier, W., Kendrick, K. M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.022 · Cited by 97
The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects
Dell’Osso, B. M., Palazzo, C., Oldani, L., & Altamura, A. C. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00217.x · Cited by 96
Marquand, A. F., Simoni, S. D., O’Daly, O., Williams, S., Mourão-Miranda, J., & Mehta, M. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.9 · Cited by 96
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice
Mizoguchi, H., Takuma, K., Fukakusa, A., Ito, Y., Nakatani, A., Ibi, D., Kim, H., & Yamada, K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0955-0 · Cited by 93
Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence
Turner, T. H., LaRowe, S. D., Horner, M. D., Herron, J. E., & Malcolm, R. J. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.03.009 · Cited by 90
Ana, E. J. S., Rounsaville, B. J., Frankforter, T. L., Nich, C., Babuscio, T. A., Poling, J. C., Gonsai, K., Hill, K. P., & Carroll, K. M. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.023 · Cited by 90
Self-citationAtomoxetine and Stroop Task Performance in Adult Attention-Deficit/Hyperactivity Disorder
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Seidman, L. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.664 · Cited by 89
Wee, S., & Woolverton, W. L. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.010 · Cited by 87
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence
Brady, K. T., Gray, K. M., & Tolliver, B. K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.017 · Cited by 85
Kempel, P., Lampe, K., Parnefjord, R., Hennig, J., & Kunert, H. J. (2003) · Neuropsychobiology · doi:10.1159/000072884 · Cited by 82
Self-regulation and treatment retention in cocaine dependent individuals: A longitudinal study
Verdejo‐García, A., Espinosa, P. B., Lozano, O. M., Vergara‐Moragues, E., González‐Sáiz, F., Fernández‐Calderón, F., Acedos, I. B., & Pérez-García, M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.025 · Cited by 82
Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors☆
Yakir, A., Rigbi, A., Kanyas, K., Pollak, Y., KAHANA, G., Karni, O., Eitan, R., Kertzman, S., & Lerer, B. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.09.004 · Cited by 82
Carroll, K. M., Kiluk, B. D., Nich, C., Babuscio, T. A., Brewer, J. A., Potenza, M. N., Ball, S. A., Martino, S., Rounsaville, B. J., & Lejuez, C. W. (2010) · Substance Use & Misuse · doi:10.3109/10826084.2011.521069 · Cited by 81
Self-citationAcute Modafinil Effects on Attention and Inhibitory Control in Methamphetamine-Dependent Humans
Dean, A. C., Sevak, R. J., Monterosso, J. R., Hellemann, G., Sugar, C. A., & London, E. D. (2011) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2011.72.943 · Cited by 80
Dunbar, G. C., Inglis, F., Kuchibhatla, R., Sharma, T., Tomlinson, M., & Wamsley, J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107066855 · Cited by 75
Kiluk, B. D., Nich, C., & Carroll, K. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.019 · Cited by 74
Self-citationMinocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Sofuoglu, M., Mooney, M. E., Kosten, T. R., Waters, A. J., & Hashimoto, K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2014-5 · Cited by 70
Self-citationCognitive status of young and older cigarette smokers: Data from the international brain database
Paul, R. H., Brickman, A. M., Cohen, R. A., Williams, L. M., NIAURA, R. S., Pöğün, Ş., Clark, C. R., Gunstad, J., & Gordon, E. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.04.012 · Cited by 68
Cognitive function as an emerging treatment target for marijuana addiction.
Sofuoglu, M., Sugarman, D. E., & Carroll, K. M. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0019295 · Cited by 68
Self-citationKalechstein, A. D., De La Garza, II, & Newton, T. F. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00052.x · Cited by 67 · cited 1×
“Furthermore, treatment with 400 mg/day of modafinil for 3 days improved working memory function in methamphetamine dependent individuals who had impaired working memory function at baseline (Kalechstein et al., 2010).”
BackgroundAharonovich, E., Brooks, A. C., Nunes, E. V., & Hasin, D. S. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.009 · Cited by 67
Wagner, M., Schulze‐Rauschenbach, S., Petrovsky, N., Brinkmeyer, J., von der Goltz, C., Gründer, G., Spreckelmeyer, K. N., Wienker, T. F., Diaz-Lacava, A. N., Mobascher, A., et al. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00429.x · Cited by 63
Bisaga, A. M., Aharonovich, E., Cheng, W. Y., LEVIN, F. R., Mariani, J. J., Raby, W. N., & Nunes, E. V. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.04.006 · Cited by 59
Historical Review of Computer-assisted Cognitive Retraining
Lynch, B. (2002) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200210000-00006 · Cited by 59
Attention-modulating effects of cognitive enhancers
Levin, E. D., Bushnell, P. J., & Rezvani, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.008 · Cited by 54
Dean, A. C., London, E. D., Sugar, C. A., Ramirez, C. M., Swanson, A., Heinzerling, K. G., Kalechstein, A. D., & SHOPTAW, S. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.008 · Cited by 50
Contingency management treatments
Petry, N. M. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.022293 · Cited by 50
Prospective matching of alcoholic clients to cognitive-behavioral or interactional group therapy.
Kadden, R. M., Litt, M. D., Cooney, N. L., Kabela, E., & Getter, H. (2001) · Journal of Studies on Alcohol · doi:10.15288/jsa.2001.62.359 · Cited by 47
Hester, R., Lee, N., Pennay, A., Nielsen, S., & Ferris, J. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021791 · Cited by 42
Galantamine improves sustained attention in chronic cocaine users.
Sofuoglu, M., Waters, A. J., Poling, J. C., & Carroll, K. M. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0022213 · Cited by 41
Self-citationPharmacologic management of relapse prevention in addictive disorders
Sofuoglu, M., & Kosten, T. R. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.06.002 · Cited by 32
Self-citationGrégoire, S., Rivalan, M., Le Moine, C., & Dellu-Hagedorn, F. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.12.003 · Cited by 30
Sofuoglu, M., Herman, A. I., Li, Y., & Waters, A. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2763-4 · Cited by 30
Self-citationEffects of Galantamine on Cocaine Use in Chronic Cocaine Users
Sofuoglu, M., & Carroll, K. M. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00130.x · Cited by 29
Self-citationHow We Say No: Norepinephrine, Inferior Frontal Gyrus, and Response Inhibition
Aston‐Jones, G., & Gold, J. I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.022 · Cited by 29
Price, K. L., DeSantis, S. M., Simpson, A. N., Tolliver, B. K., McRae‐Clark, A. L., Saladin, M. E., Baker, N. L., Wagner, M. T., & Brady, K. T. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00164.x · Cited by 28
Swartz, B. E., McDonald, C. R., Patel, A., & Torgersen, D. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181633461 · Cited by 20 · cited 2×
“Guanfacine has been demonstrated to improve working memory performance in healthy volunteers (Jakala et al., 1999; Swartz et al., 2008a) and sustained attention in individuals with schizophrenia (Friedman et al., 2001) or ADHD (Scahill et al., Neuropharmacology.”
BackgroundSarter, M. F., Bruno, J. P., Parikh, V., Martínez, V., Kozak, R., & Richards, J. B. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_4 · Cited by 17
Biological Treatments for Amfetamine Dependence
Hill, K. P., & Sofuoglu, M. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00005 · Cited by 16
Self-citationCombined treatments for substance dependence.
Carroll, K. M. (2004) · American Psychological Association eBooks · doi:10.1037/10415-009 · Cited by 5
Self-citation
Cited by
Dong, G., & Potenza, M. N. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.005 · Cited by 559
Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis.
Smith, J. L., Mattick, R. P., Jamadar, S. D., & Iredale, J. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.009 · Cited by 546
Sex differences in stress-related alcohol use
Peltier, M. R., Verplaetse, T. L., Mineur, Y. S., Petrakis, I. L., Cosgrove, K. P., Picciotto, M. R., & McKee, S. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100149 · Cited by 413
Neuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 322
Cognitive Training in Mental Disorders: Update and Future Directions
Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13081075 · Cited by 318
Metadata
- Authors
- Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 64
- Pages
- 452-463
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2055622849
- Cited by
- 298
- References
- 174
- FWCI
- 18.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.